ATE137806T1 - Verfahren zur identifizierung von bakterien - Google Patents

Verfahren zur identifizierung von bakterien

Info

Publication number
ATE137806T1
ATE137806T1 AT89909671T AT89909671T ATE137806T1 AT E137806 T1 ATE137806 T1 AT E137806T1 AT 89909671 T AT89909671 T AT 89909671T AT 89909671 T AT89909671 T AT 89909671T AT E137806 T1 ATE137806 T1 AT E137806T1
Authority
AT
Austria
Prior art keywords
antisense oligonucleotide
operon
macromolecular synthesis
stranded dna
single stranded
Prior art date
Application number
AT89909671T
Other languages
English (en)
Inventor
James R Lupski
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Application granted granted Critical
Publication of ATE137806T1 publication Critical patent/ATE137806T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3517—Marker; Tag
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT89909671T 1988-07-05 1989-06-30 Verfahren zur identifizierung von bakterien ATE137806T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21513588A 1988-07-05 1988-07-05

Publications (1)

Publication Number Publication Date
ATE137806T1 true ATE137806T1 (de) 1996-05-15

Family

ID=22801802

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89909671T ATE137806T1 (de) 1988-07-05 1989-06-30 Verfahren zur identifizierung von bakterien

Country Status (7)

Country Link
EP (1) EP0424473B1 (de)
JP (1) JPH03505672A (de)
AT (1) ATE137806T1 (de)
AU (1) AU4180889A (de)
CA (1) CA1340796C (de)
DE (1) DE68926455T2 (de)
WO (1) WO1990000624A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294533A (en) * 1988-07-05 1994-03-15 Baylor College Of Medicine Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
FR2651130B1 (fr) * 1989-08-23 1991-12-13 Roussel Uclaf Sequence d'oligonucleotides anti-sens, anti-arn message du tnf alpha, procede de preparation, application a titre de medicaments et compositions pharmaceutiques.
US5271941A (en) * 1990-11-02 1993-12-21 Cho Chung Yoon S Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
KR940703677A (ko) * 1991-12-31 1994-12-12 토루 페더슨 약물내성 말라리아에 대해 활성인 항기생충 올리고누클레오티드(antipar-asitic oligonucleotides active against drug resistant malaria)
EP0707651A1 (de) * 1993-04-26 1996-04-24 University Of Victoria Innovation And Development Corporation Verfahren und zusammensetzungen zur detektion von salmonella
WO1994027615A1 (en) * 1993-05-26 1994-12-08 Genta Incorporated Oligomer conjugates and their use
US6440660B1 (en) 1995-11-17 2002-08-27 Hybridon, Inc. Oligonucleotide mediated reversal of drug resistance
US6096499A (en) * 1996-03-22 2000-08-01 Geron Corporation Mammalian DNA primase screen and activity modulating agents
AU4672097A (en) * 1996-10-01 1998-04-24 Advanced Research And Technology Institute, Inc. Methods and compositions for inhibiting bacterial growth
US6300318B1 (en) * 1997-09-16 2001-10-09 Peter E. Nielsen Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor
WO1999067400A1 (en) * 1998-06-24 1999-12-29 Musc Foundation For Research Development Tissue-specific and target rna-specific ribozymes
WO2000061804A1 (en) 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US6271359B1 (en) 1999-04-14 2001-08-07 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
EP1210365A2 (de) * 1999-08-17 2002-06-05 Beth Israel Deaconess Medical Center, Inc. Verfahren und zusammensetzungen zur wiederherstellung der empfindlichkeit zur antibiotika in glykopeptid-resistente enterococcus
US10400291B2 (en) 2014-06-27 2019-09-03 The Regents Of The University Of Michigan Method for bacterial species identification and strain typing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
WO1983001451A1 (en) * 1981-10-23 1983-04-28 Molecular Biosystems Inc Oligonucleotide therapeutic agent and methods of making same
US4740463A (en) * 1984-04-13 1988-04-26 Massachusetts Institute Of Technology Methods and artificial genes for antagonizing the function of an oncogene
US5024943A (en) * 1985-11-07 1991-06-18 Gist-Brocades Regulatory region cloning and analysis plasmid for bacillus
FR2596774B1 (fr) * 1986-04-04 1988-07-22 Pasteur Institut Sondes oligonucleotidiques et procedes pour la detection par hybridation des acides nucleiques de bacteries et autres etres vivants
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
US4801540A (en) * 1986-10-17 1989-01-31 Calgene, Inc. PG gene and its use in plants

Also Published As

Publication number Publication date
EP0424473B1 (de) 1996-05-08
DE68926455T2 (de) 1996-10-31
EP0424473A4 (en) 1992-12-09
EP0424473A1 (de) 1991-05-02
CA1340796C (en) 1999-10-19
JPH03505672A (ja) 1991-12-12
AU4180889A (en) 1990-02-05
WO1990000624A1 (en) 1990-01-25
DE68926455D1 (de) 1996-06-13

Similar Documents

Publication Publication Date Title
CA2048450A1 (en) Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
ATE137806T1 (de) Verfahren zur identifizierung von bakterien
DE58908694D1 (de) Oligonucleotidbank und verfahren zur dna-sequenzierung.
ATE515510T1 (de) Durch dna-abschnitte unterbrochene modifizierte oligonukleotide
DE69729179D1 (de) Kohlenhydratmodifizierte luckenhafte oligonukleotide
EP0828849A4 (de) Oligonukleotidliganden mit hoher affinität für wachstumsfaktoren
NO930515L (no) Oligonukleotider for modulering av effektene av cytomegalovirusinfeksjoner
ATE419262T1 (de) 2'-o-acetamido-modifizierte monomere und oligomere
DE69331665D1 (de) Methode zur behandlung von nukleinsäureproben
DE69632466D1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DE69627314D1 (de) Kettenabbruchgruppen, ihre verwendung zur sequenzierung und synthese von nukleinsäuren und verfahren zu ihrer herstellung
DE59611371D1 (de) Verfahren zur Herstellung von Erythropoietin frei von tierischen Proteinen
BR9307192A (pt) Processo para determinar a sequência de nucleotídeos de um oligonucleotídeo de amostra
DE3583564D1 (de) Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
ATE258596T1 (de) Antigens-nukleinsäure enthaltende pharmazeutische zusammensetzung zur verbeugung und/oder behandlung von neuronalen verletzungen, entartungen und zellentot, und zur behandlung von neoplasmen
Atmadja et al. The tertiary folding of Escherichia coli 16S RNA, as studied by in situ intra-RNA cross-linking of 30S ribosomal subunits with bis-(2-chloroethyI)-methylamine
GB9312508D0 (en) Compounds
DE69638166D1 (de) Integrin-gekoppelte kinase, ihre hemmstoffe und deren gebrauch für verfahren zur therapeutischen behandlung; gentherapie und bereitstellung von hemmstoffen, die als pseudosubstrate wirken
ATE212382T1 (de) Verfahren zur sequenzierung durch oligomerhybridisierung
ATE443152T1 (de) Verfahren und dns-konstrukte zur hemmung der genexpression in bakterien.
UA43308C2 (uk) Спосіб надання рослині резистентності до склеротиніозу
RU2002109243A (ru) Способ идентификации фармацевтических агентов из растительных экстрактов
RU99111501A (ru) Способ идентификации фармацевтических агентов из растительных экстрактов
ATE108834T1 (de) Spezifische nukleinsäurefragmente des menschlichen villingens, ihre anwendung für diagnostische zwecke.
WO1993013204A3 (de) Mittel zur stimulierung der teilungsaktivität tierischer zellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee